The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Lyashenko E.N.

V.I. Vernadsky Crimean Federal University — S.I. Georgievsky Red Banner Medical Institute

Aramyan E.E.

V.I. Vernadsky Crimean Federal University — S.I. Georgievsky Red Banner Medical Institute

Zinchenko M.S.

V.I. Vernadsky Crimean Federal University — S.I. Georgievsky Red Banner Medical Institute

«Cytokine storm» as an immunopathologic reaction in pregnant women in the first trimester

Authors:

Lyashenko E.N., Aramyan E.E., Zinchenko M.S.

More about the authors

Read: 1403 times


To cite this article:

Lyashenko EN, Aramyan EE, Zinchenko MS. «Cytokine storm» as an immunopathologic reaction in pregnant women in the first trimester. Russian Bulletin of Obstetrician-Gynecologist. 2024;24(5):19‑24. (In Russ.)
https://doi.org/10.17116/rosakush20242405119

Recommended articles:
Sexual function of women during pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):112-117
Immu­nological aspe­cts of reccurent pregnancy loss. Russian Journal of Human Reproduction. 2024;(5):64-71
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146

References:

  1. Potapnev M.P. Cytokine storm: causes and consequences. Immunologiya. 2021;42:2:175-188. (In Russ.).
  2. Tyulyandina E.V., Piskov D.A. Cytokine storm: Features of pathogenesis, role in the development of viral infection. Ustoichivoe razvitie nauki i obrazovaniya. 2019;1:256-260. (In Russ.).
  3. Kostyuk S.A., Simirskii V.V., Gorbich Yu.L., Anis’ko L.A., Poluyan O.S. Cytokine storm in COVID-19. Meditsinskie novosti. 2020;10:313:4-8. 
  4. Sakhautdinova I.V., Zasyadkin I.S., Tayupova I.M., Khaibullina A.R. The effect of the new coronavirus infection COVID-19 on the immunological status of pregnant women. Ural’skii meditsinskii zhurnal. 2022;21:4:72-77. (In Russ.).
  5. Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383:23:2255-2273. https://doi.org/10.1056/NEJMra2026131
  6. Tang XD, Ji TT, Dong JR, Feng H, Chen FQ, Chen X, Zhao HY, Chen DK, Ma WT. Pathogenesis and treatment of cytokine storm induced by infectious diseases. Int J Mol Sci. 2021;22:23:13009. https://doi.org/10.3390/ijms222313009
  7. Nile SH, Nile A, Qiu J. Li L, Jia X, Kai G. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66-70.  https://doi.org/10.1016/j.cytogfr.2020.05.002
  8. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19. J Infect. 2020;80:6:607-613.  https://doi.org/10.1016/j.jinf.2020.03.037
  9. Tereshchenko I.V., Kayushev P.E. Tumor necrosis factor α and its role in pathology. RMZh. Meditsinskoe obozrenie. 2022;6:9:523-527. (In Russ.). https://doi.org/10.32364/2587-6821-2022-6-9-523-527
  10. Obstetrics. Ed. G.M. Savel’eva. M.: Meditsina. 2000;83-85. (In Russ.).
  11. Naidu SAG, Clemens RA, Pressman P, Zaigham M, Kadkhoda K, Davies KJA, Naidu AS. COVID-19 during pregnancy and postpartum. J Diet Suppl. 2022;19:1:115-142.  https://doi.org/10.1080/19390211.2020.1834049
  12. Obuchowska A, Standyło A, Obuchowska K, Kimber-Trojnar Ż, Leszczyńska-Gorzelak B. Cytokine storms in the course of COVID-19 and haemophagocytic lymphohistiocytosis in pregnant and postpartum women. Biomolecules. 2021;11:8:1202. https://doi.org/10.3390/biom11081202
  13. Figueiredo CP, Fontes-Dantas FL, da Poian AT, Clarke JR. SARS-CoV-2-associated cytokine storm during pregnancy as a possible risk factor for neuropsychiatric disorder development in post-pandemic infants. Neuropharmacology. 2021;201:108841. https://doi.org/10.1016/j.neuropharm.2021.108841
  14. Gashimova N.R., Pankrat’eva L.L., Bitsadze V.O., Khizroeva D.Kh., Makatsariya N.A., Tret’yakova M.V., Shkoda A.S., Grigor’eva K.N., Tsibizova V.I., Gri Zh.K., Yakubova F.E., Blinov D.V., Makatsariya A.D. Intrauterine activation of the fetal immune system in response to COVID-19 in the mother. Akusherstvo, ginekologiya i reproduktsiya. 2023;17:2:188-201. (In Russ.).
  15. Wenling Y, Junchao Q, Xiao Z, Ouyang S. Pregnancy and COVID-19: management and challenges. Rev Inst Med Trop Sao Paulo. 2020;62:e62.  https://doi.org/10.1590/s1678-9946202062062
  16. Kumar R, Yeni CM, Utami NA, Masand R, Asrani RK, Patel SK, Kumar A, Yatoo MI, Tiwari R, Natesan S, Vora KS, Nainu F, Bilal M, Dhawan M, Emran TB, Ahmad T, Harapan H, Dhama K. SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies-a narrative review. J Infect Public Health. 2021;14:7:863-875.  https://doi.org/10.1016/j.jiph.2021.04.005
  17. Mereke A., Oralkhan Zh., Zhurabekova G. The effectiveness of treatment and CURE OF SARS-COV-2. West Kazakhstan Medical Journal. 2022;1:64:4-8. (In Russ.). https://doi.org/10.24412/2707-6180-2022-64-4-8
  18. Vesce F, Battisti C, Crudo M. The Inflammatory cytokine imbalance for miscarriage, pregnancy loss and COVID-19 pneumonia. Front Immunol. 2022;13:861245. https://doi.org/10.3389/fimmu.2022.861245
  19. Grigor’eva E.V., Tyapkina D.A., Borodai A.A., Blokhin I.S., Kondrashkin I.E., Polidanov M.A., Rebrov A.P. On the effectiveness of COVID-19 treatment in pregnant women. Clinician. 2023;17:2:28-38. (In Russ.).
  20. Tanacan A, Yazihan N, Erol SA, Anuk AT, Yucel Yetiskin FD, Biriken D, Ozgu-Erdinc AS, Keskin HL, Moraloglu Tekin O, Sahin D. The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective case-control study. Cytokine. 2021;140:155431. https://doi.org/10.1016/j.cyto.2021.155431
  21. Vukolova V.A., En’kova E.V., Ryzhikov Yu.S., Sokol E.B., Ippolitova L.I., Kiseleva E.V., Korzh E.V. Assessment of the course of pregnancy, childbirth and fetal condition in women with COVID-19. Vestnik novykh meditsinskikh tekhnologii. Electronic Edition. 2020;14:6:56-62. (In Russ.). https://doi.org/10.24411/2075-4094-2020-16778
  22. Lan X, Guo L, Zhu S, Cao Y, Niu Y, Han S, Li Z, Li Y, Yan J. First-trimester serum cytokine profile in pregnancies conceived after assisted reproductive technology (ART) with subsequent pregnancy-induced hypertension. Front Immunol. 2022;13:930582. https://doi.org/10.3389/fimmu.2022.930582
  23. Lyazgiyan K.S. Clinical and immunological features of the new coronavirus infection SARS-CoV-2 in pregnant women. Byulleten’ fisiologii i patologii dykhaniya. 2021;80:91-99. (In Russ.).
  24. Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry. 2015;2:258-270. 
  25. Granja MG, Oliveira ACDR, de Figueiredo CS, Gomes AP, Ferreira EC, Giestal-de-Araujo E, de Castro-Faria-Neto HC. SARS-CoV-2 infection in pregnant women: Neuroimmune-endocrine changes at the maternal-fetal interface. Neuroimmunomodulation. 2021;28:1:1-21.  https://doi.org/10.1159/000515556
  26. Thepmankorn P, Bach J, Lasfar A, Zhao X, Souayah S, Chong ZZ, Souayah N. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations. Cytokine. 2021;138:155404. https://doi.org/10.1016/j.cyto.2020.155404
  27. Veleri S. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients. Exp Brain Res. 2022;240:1:9-25.  https://doi.org/10.1007/s00221-021-06244-z
  28. Jamieson DJ, Rasmussen SA. An update on COVID-19 and pregnancy. Am J Obstet Gynecol. 2022;226:2:177-186.  https://doi.org/10.1016/j.ajog.2021.08.054
  29. Quincozes-Santos A, Rosa RL, Tureta EF, Bobermin LD, Berger M, Guimarães JA, Santi L, Beys-da-Silva WO. COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders. Brain Behav Immun Health. 2021;11:100196. https://doi.org/10.1016/j.bbih.2020.100196
  30. Ayed M, Embaireeg A, Kartam M, More K, Alqallaf M, AlNafisi A, Alsaffar Z, Bahzad Z, Buhamad Y, Alsayegh H., Al-Fouzan W, Alkandari H. Neurodevelopmental outcomes of infants born to mothers with SARS-CoV-2 infections during pregnancy: a national prospective study in Kuwait. BMC Pediatr. 2022;22:1:319.  https://doi.org/10.1186/s12887-022-03359-2
  31. Gareeva A.E. Modern view on neurobiological hypotheses of schizophrenia. Zhurnal vysshei nervnoi deyatel’nosti im. I.P. Pavlova. 2019:69:4:437-455. (In Russ.). https://doi.org/10.1134/S0044467719040038
  32. Maksimova N.M., Bulgakova T.S., Uzbekov M.G. The role of cytokines in the pathogenesis and therapy of mental disorders. Sotsial’naya i klinicheskaya psikhiatriya. 2019;29:3:71-77. (In Russ.).
  33. Joma M, Fovet CM, Seddiki N, Gressens P, Laforge M. COVID-19 and pregnancy: Vertical transmission and inflammation impact on newborns. Vaccines (Basel). 2021;9:4:391.  https://doi.org/10.3390/vaccines9040391
  34. Kalimatova D.M., Dobrokhotova Yu.E. Features of the course of pregnancy and childbirth in COVID-19 infection. Prakticheskaya meditsina. 2020;18:2:6-11. (In Russ.).
  35. Yuldasheva G.R., Ismoilova Sh.T., Dzhabbarova Yu.K., Musakhodzhaeva D.A. The influence of a new COVID-19 viral infection on a pregnant woman, fetus and newborn. Zhurnal teoreticheskoi i klinicheskoi meditsiny. 2021;4:133-138. (In Russ.).
  36. Jarmund AH, Giskeødegård GF, Ryssdal M, Steinkjer B, Stokkeland LMT, Madssen TS, Stafne SN, Stridsklev S, Moholdt T, Heimstad R, Vanky E, Iversen AC. Cytokine patterns in maternal serum from first trimester to term and beyond. Front Immunol. 2021;12:752660. https://doi.org/10.3389/fimmu.2021.752660
  37. Norooznezhad AH, Shamshirsaz AA, Hantoushzadeh S. Labor could increase systemic inflammation and cause or deteriorate cytokine storm in COVID-19. Iran J Immunol. 2022;19:3:330-336.  https://doi.org/10.22034/iji.2022.93951.2267
  38. Trinh IV, Desai SP, Ley SH, Mo Z, Sato R, Pridjian GC, Longo SA, Shaffer JG, Robinson JE, Norton EB, Piedimonte G. Prenatal infection by respiratory viruses is associated with immuno-inflammatory responses in the fetus. Am J Respir Crit Care Med. 2023. https://doi.org/10.1164/rccm.202308-1461OC
  39. Tsvetov V.M., Mirzaev K.B. Clinical and pharmacological aspects of the use of medicines in COVID-19 in pregnant women. Farmateka. 2020;27:14:16-27. (In Russ.). https://doi.org/10.18565/pharmateca.2020.14.16-27
  40. Chen G, Liao Q, Ai J, Yang B, Bai H, Chen J, Liu F, Cao Y, Liu H, Li K. Immune Response to COVID-19 during pregnancy. Front Immunol. 2021;12:675476. https://doi.org/10.3389/fimmu.2021.675476
  41. Ershov A.V., Surova V.D., Dolgikh V.T., Dolgikh T.I. Cytokine storm in a new coronavirus infection and ways to correct it. Antibiotiki i khimioterapiya. 2020;65:11-12:27-37. (In Russ.).
  42. Jiménez-Lozano I, Caro-Teller JM, Fernández-Hidalgo N, Miarons M, Frick MA, Batllori Badia E, Serrano B, Parramon-Teixidó CJ, Camba-Longueira F, Moral-Pumarega MT, San Juan-Garrido R, Cabañas Poy MJ, Suy A, Gorgas Torner MQ. Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study. J Clin Pharm Ther. 2021;46:4:1062-1070. https://doi.org/10.1111/jcpt.13394
  43. Peng J, Fu M, Mei H, Zheng H. Liang G, She X, Wang Q, Liu W. Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: A systematic review and meta-analysis. Rev Med Virol. 2022;32:3:e2295. https://doi.org/10.1002/rmv.2295
  44. Vasilevskii I.V. The role of cytokines in SARS-CoV-2 infection and cytokine storm blockade pathways. Healthcare (Minsk). 2022;3:900:31-41. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.